SlideShare a Scribd company logo
1
 Defination
“Stimulants are a substance which
tends to increase behavioral
activity when administered”
Few clinical uses, Important as drugs of abuse.
Factors that limit the therapeutic usefulness include:
1.Dependence: Psychological and physiological.
2.Tolerance to the euphoric and anorectic effects
are classified according to their action into:
Psychomotor stimulants
Hallucinogen (psychotomimetic or psychedelics) drugs
3
1. Psychomotor stimulants
cause: Excitement, Euphoria, Decrease feeling of fatigue
& Increase motor activity
Ex., Methylxanthines (caffeine, theobromine, theophylline), nicotine,
cocaine, amphetamine, atomoxetine, modafinil, methylphenidate.
2. Hallucinogens (psychotomimetic):
Affect thought, perception, and mood, therefore produce
profound changes in thought patterns & mood,
little effect on the brain stem & spinal cord
Ex., Lysergic acid diethylamide (LSD), Phencyclidine (PCP),
Tetrahydrocannabinol (THC), Rimonabant.
4
Q. What are Stimulants?
Answer. Chemical stracture are similar to
monoamine neurotransmitters. All are indirect-
acting sympathomimetics:
1. Many CNS stimulants release catecholamines,
Therefore, their effects are abolished by prior treatment with reserpine or
guanethidine
Ex: amphetamine, dextroamphetamine,
methamphetamine, methylphenidate (Ritalin),
ephedrine, pseudoephedrine (a stereoisomer of
ephedrine), tyramine.
2. Other CNS stimulants block the reuptake of
catecholamines (NE and DA) and serotonin:
EX. Cocaine, sibutramine (reduct)®
, modafinil
5
Attention Deficit Hyperactivity Disorder (ADHD);
lack the ability to be involved in any one activity for
longer than a few minutes.
Narcolepsy: It is a relatively rare sleep disorder, that is
characterized by uncontrollable bouts of sleepiness
during the day. It is sometimes accompanied by
catalepsy, a loss in muscle control, or even paralysis
brought on by strong emotion, such as laughter.
Contraindications: patients with anorexia, insomnia,
asthenia, psychopathic personality, a history of
homicidal or suicidal tendencies.
6
I. Cocaine, Crack (free base or hydrochloride).
II. Amphetamines:
D-Amphetamine, Methamphetamine, methylphenidate
(use to treat attention deficit disorders in children),
phenmetrazine (Preludin) - used to treat obesity,
III. Methylxanthines: caffeine (coffee), theophyline
(tea), theobromide (chocolate).
 Alkaloid from Erythroxylon coca
 Indigenous to western South America
 Coca leaves used for religious, mystical,
social, stimulant, and medicinal purposes
 Main stimulant uses: endurance, feeling of
well-being, alleviate hunger
 Medical uses: local anesthetic,
vasoconstrictor
 alertness/vigilance, concentration
 mental acuity, sensory awareness
 euphoria/elevated mood
 brain electrical activity
 self-confidence, grandiosity
 need for sleep (insomnia)
 appetite
 brain blood flow, glucose metabolism
London et al., 1999
 sexual desire, but cocaine can  performance
 anxiety, suspiciousness
 convulsions, tremor, seizure
 psychosis, delirium
 locomotion at low/moderate doses
 repetitiveness, stereotypy at high doses
 reinforcement/addiction
 judgement, complex multi-tasking
 Blood pressure
 Blood sugar
 Heart rate
Irregular heart beat
Vasoconstriction
 Body temperature
Bronchodialation
& Impaired breathing
Fight/Flight/Fright Syndrome
(sympathetic nervous system arousal)
 Routes of administration
◦ Insufflated (snorted)
◦ IV (mainlined)
◦ Inhaled (freebased)
◦ Oral
 Cocaine has a local anesthetic action
that represents the only current
rationale for the therapeutic use of cocaine.
 For example, cocaine is applied topically as a
local anesthetic during eye, ear, nose, and
throat surgery.
 Whereas the local anesthetic action of cocaine
is due to a block of voltage-activated sodium
channels, an interaction with potassium
channels may contribute to the ability of
cocaine to cause cardiac arrhythmias.
 Both cocaine and amphetamines penetrate BBB
easily
 Half-lives
◦ Cocaine: ~ 50-90 min
◦ Amphetamine: ~ 5-10 hours
◦ Meth: ~ 12 hours
 Metabolites include active and inactive compounds
 Cocaine is unusual in that it “autometabolizes” in
the blood in addition to normal liver metabolism.
◦ Cocaine ----> norcocaine, ecgonine methyl ester, benzoylecgonine
 High abuse potential
 Physical and psychological dependence
 Tolerance to euphoria, appetite suppression;
sensitization to psychomotor
 Withdrawal
◦ Physically mild to moderate (hunger, fatigue, anxiety, irritability,
depression, panic attacks, dysphoric syndrome)
 Dysphoric syndrome (1-5 days after the crash): characterized by
decreased activity, amotivation, intense boredom and anhedonia,
intense “craving” for cocaine. May last 1-10 weeks.
 Intense cravings
 Route of administration important to addiction risk
 Synthetic analog of ephedrine,
active ingredient in mahuang
 Mahuang used in China for
asthma
◦ Chinese (Mandarin) má huáng : má,
hemp + huáng, yellow
 Methamphetamine and
Methylphenidate (Ritalin) are
very similar
 Medical uses: obesity, ADHD,
Amphetamine is a noncatecholaminergic
sympathetic amine that shows neurologic and
clinical effects quite similar to those of cocaine.
Dextroamphetamine is the major member of this
class of compounds.
Methamphetamine is a derivative of amphetamine
that can be smoked, and it is preferred by many
abusers.
 Adverse effects:
 - Cardiovascular: Hypertension (7% to 22%,
pediatric )
 - Endocrine metabolic: Weight loss (4% to
9%, pediatric; 11%, adults )
 - Gastrointestinal: Abdominal pain (11% to
14%, pediatrics ), Loss of appetite (22% to 36%),
Xerostomia (35% )
 - Neurologic: Headache (26% ), Insomnia ‫ارق‬
)12 % to 17%, pediatric; 27%, adults )
 - Psychiatric: Feeling nervous (6% ) 
 After injecting,  the mice with amphetamine you
well notice: 
- Hair erection
 - Licking, gnawing.
 - Stereotype
 - Sniffing 
Methylxanthines
 The methylxanthines include theophylline which
is found in tea; theobromine found in cocoa;
and caffeine .
 Caffeine, the most widely consumed stimulant
in the world, is found in highest concentration in
coffee, but it is also present in tea, cola drinks,
chocolate candy, and cocoa.
Several mechanisms have been proposed
for the actions of methylxanthines,
including translocation of extracellular
calcium, increase in cyclic adenosine
monophosphate and cyclic guanosine
monophosphate caused by inhibition of
phosphodiesterase, and blockade of adenosine
receptors.
The latter most likely accounts for the actions
achieved by the usual consumption of caffeine-
containing beverages
 CNS: The caffeine contained in one to two
cups of coffee causes a decrease in fatigue
and increased mental alertness as a result of
stimulating the cortex and other areas of the brain.
 Consumption of 1.5 g of caffeine (12 to 15 cups of
coffee) produces anxiety and tremors.
 The spinal cord is stimulated only by very high doses
of caffeine.
 Tolerance can rapidly develop to the stimulating
properties of caffeine; withdrawal consists of feelings
of fatigue and sedation.
 Cardiovascular system:
 A high dose of caffeine has positive inotropic and
chronotropic effects on the heart.
 Diuretic action:
 Caffeine has a mild diuretic action that increases
urinary output of sodium, chloride, and potassium.
 Gastric mucosa:
 Because all methylxanthines stimulate secretion of
hydrochloric acid from the gastric mucosa,
individuals with peptic ulcers should avoid
beverages containing methylxanthines
The methylxanthines are well absorbed
orally.
Caffeine distributes throughout the body,
including the brain.
The drugs cross the placenta to the fetus and is
secreted into the mother's milk.
All the methylxanthines are metabolized in the
liver,
generally by the CYP1A2 pathway, and the
metabolites are then excreted in the urine.
 Moderate doses of caffeine cause
insomnia, anxiety, and agitation.
 The lethal dose is about 10 g of caffeine (about
100 cups of coffee), which induces cardiac
arrhythmias; death from caffeine is thus highly
unlikely.
 Lethargy, irritability, and headache occur in
users who have routinely consumed more than
600 mg of caffeine per day (roughly six cups of
coffee per day) and then suddenly stop.
Nicotine is the active ingredient in
tobacco.
Although this drug is not currently used therapeutically,
nicotine remains important, because it is second only
to caffeine as the most widely used CNS stimulant
and second only to alcohol as the most abused drug.
 In combination with the tars and carbon monoxide
found in cigarette smoke, nicotine represents a
serious risk factor for lung and cardiovascular
disease, various cancers, as well as other illnesses.
Dependency on the drug is not easily overcome.
 In low doses, nicotine causes ganglionic
stimulation by depolarization.
 At high doses, nicotine causes ganglionic
blockade.
 Nicotine receptors exist at a number of sites in the
CNS, which participate in the stimulant attributes of
the drug.
 Nicotine is highly lipid soluble and readily
crosses the blood-brain barrier.
 Cigarette smoking or administration of low
doses of nicotine produces some degree of
euphoria and arousal as well as relaxation.
 It improves attention, learning, problem solving,
and reaction time.
 High doses of nicotine result in central respiratory
paralysis .
Because nicotine is highly lipid soluble,
absorption readily occurs via the oral
mucosa, lungs, mucosa, and skin.
Nicotine crosses the placental membrane and is
secreted in the milk of lactating women.
By inhaling tobacco smoke, the average smoker takes
in 1 to 2 mg of nicotine per cigarette (most cigarettes
contain 6 to 8 mg of nicotine). The acute lethal dose
is 60 mg. More than 90 percent of the nicotine
inhaled in smoke is absorbed.
 The CNS effects of nicotine include
irritability and tremors.
 Nicotine may also cause intestinal
cramps, diarrhea, and increased heart rate and
blood pressure.
 In addition, cigarette smoking increases the
rate of metabolism of number of drugs.

More Related Content

What's hot

Stimulants PowerPoint
Stimulants PowerPoint Stimulants PowerPoint
Stimulants PowerPoint bridgettebazin
 
Drug addiction a& dependence
Drug addiction a& dependenceDrug addiction a& dependence
Drug addiction a& dependence
Dr. Mohd Kaleem Khan
 
Antidepressants
AntidepressantsAntidepressants
Antidepressants
Dr. Sriram Raghavendran
 
Amphetamine
AmphetamineAmphetamine
Amphetamine
Angel Yoanna
 
Anti parkinson
Anti parkinsonAnti parkinson
Anti parkinson
education4227
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
Naser Tadvi
 
Drugs of abuse - Pharmacology
Drugs of abuse - PharmacologyDrugs of abuse - Pharmacology
Drugs of abuse - Pharmacology
Areej Abu Hanieh
 
atomoxetine & methylphenidilate
atomoxetine & methylphenidilateatomoxetine & methylphenidilate
atomoxetine & methylphenidilateDeepika Singh
 
Chapter 12 Hallucinogens
Chapter 12  HallucinogensChapter 12  Hallucinogens
Chapter 12 HallucinogensJustin Gatewood
 
Amphetamine
AmphetamineAmphetamine
Amphetamine
dr masood unar
 
Typical antipsychotics
Typical   antipsychoticsTypical   antipsychotics
Typical antipsychotics
Anant Rathi
 
ANTIDEPRESSANTS: All you need to know...by RxVichu! :)
ANTIDEPRESSANTS: All you need to know...by RxVichu! :)ANTIDEPRESSANTS: All you need to know...by RxVichu! :)
ANTIDEPRESSANTS: All you need to know...by RxVichu! :)
RxVichuZ
 
Hallucinogens pharmacology
Hallucinogens pharmacologyHallucinogens pharmacology
Hallucinogens pharmacology
Koppala RVS Chaitanya
 
Hallucinogens
HallucinogensHallucinogens
Hallucinogens
Michelle Meyer
 
CNS stimulants - Parmacology
CNS stimulants - ParmacologyCNS stimulants - Parmacology
CNS stimulants - Parmacology
Areej Abu Hanieh
 
Canabbis
CanabbisCanabbis
Canabbis
geminigems27
 
Antiparkinson's Drugs
Antiparkinson's DrugsAntiparkinson's Drugs
Antiparkinson's Drugs
Bhudev Global
 
Antidepressants - Pharmacology
 Antidepressants - Pharmacology Antidepressants - Pharmacology
Antidepressants - Pharmacology
Areej Abu Hanieh
 

What's hot (20)

Stimulants PowerPoint
Stimulants PowerPoint Stimulants PowerPoint
Stimulants PowerPoint
 
Drug addiction a& dependence
Drug addiction a& dependenceDrug addiction a& dependence
Drug addiction a& dependence
 
Antidepressants
AntidepressantsAntidepressants
Antidepressants
 
Amphetamine
AmphetamineAmphetamine
Amphetamine
 
Anti parkinson
Anti parkinsonAnti parkinson
Anti parkinson
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
 
Drugs of abuse - Pharmacology
Drugs of abuse - PharmacologyDrugs of abuse - Pharmacology
Drugs of abuse - Pharmacology
 
atomoxetine & methylphenidilate
atomoxetine & methylphenidilateatomoxetine & methylphenidilate
atomoxetine & methylphenidilate
 
Chapter 12 Hallucinogens
Chapter 12  HallucinogensChapter 12  Hallucinogens
Chapter 12 Hallucinogens
 
Amphetamine
AmphetamineAmphetamine
Amphetamine
 
Typical antipsychotics
Typical   antipsychoticsTypical   antipsychotics
Typical antipsychotics
 
ANTIDEPRESSANTS: All you need to know...by RxVichu! :)
ANTIDEPRESSANTS: All you need to know...by RxVichu! :)ANTIDEPRESSANTS: All you need to know...by RxVichu! :)
ANTIDEPRESSANTS: All you need to know...by RxVichu! :)
 
CNS Depressants
CNS DepressantsCNS Depressants
CNS Depressants
 
Hallucinogens pharmacology
Hallucinogens pharmacologyHallucinogens pharmacology
Hallucinogens pharmacology
 
Hallucinogens
HallucinogensHallucinogens
Hallucinogens
 
CNS stimulants - Parmacology
CNS stimulants - ParmacologyCNS stimulants - Parmacology
CNS stimulants - Parmacology
 
Canabbis
CanabbisCanabbis
Canabbis
 
Antiparkinson's Drugs
Antiparkinson's DrugsAntiparkinson's Drugs
Antiparkinson's Drugs
 
Ecstacy ppt
Ecstacy pptEcstacy ppt
Ecstacy ppt
 
Antidepressants - Pharmacology
 Antidepressants - Pharmacology Antidepressants - Pharmacology
Antidepressants - Pharmacology
 

Viewers also liked

Etiology and Pathogenesis of Peptic Ulcer
Etiology and Pathogenesis of Peptic UlcerEtiology and Pathogenesis of Peptic Ulcer
Etiology and Pathogenesis of Peptic Ulcer
Koppala RVS Chaitanya
 
appetite regulation
appetite regulationappetite regulation
appetite regulation
Mohanad Aljashamy
 
Chronotherapy
ChronotherapyChronotherapy
Chronotherapy
Koppala RVS Chaitanya
 
Appetite regulation
Appetite regulation   Appetite regulation
Appetite regulation
Madhumita Sen
 
Digestants, appetite stimulants and suppressants, Carminatives
Digestants, appetite stimulants and suppressants, CarminativesDigestants, appetite stimulants and suppressants, Carminatives
Digestants, appetite stimulants and suppressants, Carminatives
Koppala RVS Chaitanya
 
Appetite stimulant and
Appetite stimulant   andAppetite stimulant   and
Appetite stimulant andpctebpharm
 
Appetite Stimulants Chart
Appetite Stimulants ChartAppetite Stimulants Chart
Appetite Stimulants ChartJoseph Helms
 

Viewers also liked (7)

Etiology and Pathogenesis of Peptic Ulcer
Etiology and Pathogenesis of Peptic UlcerEtiology and Pathogenesis of Peptic Ulcer
Etiology and Pathogenesis of Peptic Ulcer
 
appetite regulation
appetite regulationappetite regulation
appetite regulation
 
Chronotherapy
ChronotherapyChronotherapy
Chronotherapy
 
Appetite regulation
Appetite regulation   Appetite regulation
Appetite regulation
 
Digestants, appetite stimulants and suppressants, Carminatives
Digestants, appetite stimulants and suppressants, CarminativesDigestants, appetite stimulants and suppressants, Carminatives
Digestants, appetite stimulants and suppressants, Carminatives
 
Appetite stimulant and
Appetite stimulant   andAppetite stimulant   and
Appetite stimulant and
 
Appetite Stimulants Chart
Appetite Stimulants ChartAppetite Stimulants Chart
Appetite Stimulants Chart
 

Similar to Stimulants

IVMS-CNS Pharmacology Intro to Drugs of Abuse III-Stimulants
IVMS-CNS Pharmacology Intro to Drugs of Abuse III-StimulantsIVMS-CNS Pharmacology Intro to Drugs of Abuse III-Stimulants
IVMS-CNS Pharmacology Intro to Drugs of Abuse III-Stimulants
Imhotep Virtual Medical School
 
8QuyYhigEyF50OSLZMog.pdf
8QuyYhigEyF50OSLZMog.pdf8QuyYhigEyF50OSLZMog.pdf
8QuyYhigEyF50OSLZMog.pdf
Imtiyaz60
 
PHAR 4472 CNS Stimulants abuse & toxicity.ppt
PHAR 4472 CNS Stimulants abuse & toxicity.pptPHAR 4472 CNS Stimulants abuse & toxicity.ppt
PHAR 4472 CNS Stimulants abuse & toxicity.ppt
PrabaNanthan
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulants
vikasaagrahari007
 
6 Pharmacology I CNS Stimulants NK, trimmed.pptx
6 Pharmacology I CNS Stimulants NK, trimmed.pptx6 Pharmacology I CNS Stimulants NK, trimmed.pptx
6 Pharmacology I CNS Stimulants NK, trimmed.pptx
Ahmad Kharousheh
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulants
Zainab&Sons
 
SUBSTANCE ABUSE.pptx
SUBSTANCE ABUSE.pptxSUBSTANCE ABUSE.pptx
SUBSTANCE ABUSE.pptx
preethiG35
 
Central Nervous System Stimulants presentation
Central Nervous System Stimulants presentationCentral Nervous System Stimulants presentation
Central Nervous System Stimulants presentation
DixitGoyal10
 
cns stimulants and drug abuse.pdf
cns stimulants and drug abuse.pdfcns stimulants and drug abuse.pdf
cns stimulants and drug abuse.pdf
Vijay Salvekar
 
substance dependance.pptx
substance dependance.pptxsubstance dependance.pptx
substance dependance.pptx
RaadAzeez1
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulantsraj kumar
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulantsraj kumar
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulantsraj kumar
 
Lect. PSYCHOSTIMUL.ppt
Lect. PSYCHOSTIMUL.pptLect. PSYCHOSTIMUL.ppt
Lect. PSYCHOSTIMUL.ppt
AdishBlaze
 
Cns stimulant by yogesh sangle
Cns stimulant by yogesh sangleCns stimulant by yogesh sangle
Cns stimulant by yogesh sangle
Ashish Agrawal
 
2-CNS-stimulant.ppt
2-CNS-stimulant.ppt2-CNS-stimulant.ppt
2-CNS-stimulant.ppt
Khadiza8
 

Similar to Stimulants (20)

IVMS-CNS Pharmacology Intro to Drugs of Abuse III-Stimulants
IVMS-CNS Pharmacology Intro to Drugs of Abuse III-StimulantsIVMS-CNS Pharmacology Intro to Drugs of Abuse III-Stimulants
IVMS-CNS Pharmacology Intro to Drugs of Abuse III-Stimulants
 
8QuyYhigEyF50OSLZMog.pdf
8QuyYhigEyF50OSLZMog.pdf8QuyYhigEyF50OSLZMog.pdf
8QuyYhigEyF50OSLZMog.pdf
 
PHAR 4472 CNS Stimulants abuse & toxicity.ppt
PHAR 4472 CNS Stimulants abuse & toxicity.pptPHAR 4472 CNS Stimulants abuse & toxicity.ppt
PHAR 4472 CNS Stimulants abuse & toxicity.ppt
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulants
 
Stimulants
Stimulants Stimulants
Stimulants
 
6 Pharmacology I CNS Stimulants NK, trimmed.pptx
6 Pharmacology I CNS Stimulants NK, trimmed.pptx6 Pharmacology I CNS Stimulants NK, trimmed.pptx
6 Pharmacology I CNS Stimulants NK, trimmed.pptx
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulants
 
SUBSTANCE ABUSE.pptx
SUBSTANCE ABUSE.pptxSUBSTANCE ABUSE.pptx
SUBSTANCE ABUSE.pptx
 
Central Nervous System Stimulants presentation
Central Nervous System Stimulants presentationCentral Nervous System Stimulants presentation
Central Nervous System Stimulants presentation
 
Pharma doa
Pharma doaPharma doa
Pharma doa
 
cns stimulants and drug abuse.pdf
cns stimulants and drug abuse.pdfcns stimulants and drug abuse.pdf
cns stimulants and drug abuse.pdf
 
The use and misuse of drugs
The use and misuse of drugsThe use and misuse of drugs
The use and misuse of drugs
 
substance dependance.pptx
substance dependance.pptxsubstance dependance.pptx
substance dependance.pptx
 
Kowsi
KowsiKowsi
Kowsi
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulants
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulants
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulants
 
Lect. PSYCHOSTIMUL.ppt
Lect. PSYCHOSTIMUL.pptLect. PSYCHOSTIMUL.ppt
Lect. PSYCHOSTIMUL.ppt
 
Cns stimulant by yogesh sangle
Cns stimulant by yogesh sangleCns stimulant by yogesh sangle
Cns stimulant by yogesh sangle
 
2-CNS-stimulant.ppt
2-CNS-stimulant.ppt2-CNS-stimulant.ppt
2-CNS-stimulant.ppt
 

More from optometry student

Care for ophthalmic instrument1
Care for ophthalmic instrument1Care for ophthalmic instrument1
Care for ophthalmic instrument1
optometry student
 
Ocular hypotensive drugs
Ocular hypotensive drugsOcular hypotensive drugs
Ocular hypotensive drugs
optometry student
 
Tissue repair, regeneration and wound healing (1)
Tissue repair, regeneration and wound healing (1)Tissue repair, regeneration and wound healing (1)
Tissue repair, regeneration and wound healing (1)optometry student
 
Hyperaemia, congestion and haemorrhage
Hyperaemia, congestion and haemorrhageHyperaemia, congestion and haemorrhage
Hyperaemia, congestion and haemorrhageoptometry student
 
NEURON SUPPORTIVE CELLS OR ANS
NEURON SUPPORTIVE CELLS OR ANSNEURON SUPPORTIVE CELLS OR ANS
NEURON SUPPORTIVE CELLS OR ANSoptometry student
 
Fertilization early embryo dev't
Fertilization early embryo dev'tFertilization early embryo dev't
Fertilization early embryo dev'toptometry student
 
Lecture 19 central nervous system (a)
Lecture 19   central nervous system (a)Lecture 19   central nervous system (a)
Lecture 19 central nervous system (a)optometry student
 
Genetic code & transcription
Genetic code & transcriptionGenetic code & transcription
Genetic code & transcriptionoptometry student
 
Epidemiology trends and healthcare implication
Epidemiology trends and healthcare implicationEpidemiology trends and healthcare implication
Epidemiology trends and healthcare implicationoptometry student
 
Primary eye care examination
Primary eye care examinationPrimary eye care examination
Primary eye care examination
optometry student
 
Microeconomics and other social parameters.
Microeconomics and other social parameters.Microeconomics and other social parameters.
Microeconomics and other social parameters.optometry student
 
Epidemiology trends and healthcare implication
Epidemiology trends and healthcare implicationEpidemiology trends and healthcare implication
Epidemiology trends and healthcare implicationoptometry student
 

More from optometry student (20)

Care for ophthalmic instrument1
Care for ophthalmic instrument1Care for ophthalmic instrument1
Care for ophthalmic instrument1
 
Ocular hypotensive drugs
Ocular hypotensive drugsOcular hypotensive drugs
Ocular hypotensive drugs
 
Tissue repair, regeneration and wound healing (1)
Tissue repair, regeneration and wound healing (1)Tissue repair, regeneration and wound healing (1)
Tissue repair, regeneration and wound healing (1)
 
Cns disorders
Cns disordersCns disorders
Cns disorders
 
Antidepressants
AntidepressantsAntidepressants
Antidepressants
 
Hyperaemia, congestion and haemorrhage
Hyperaemia, congestion and haemorrhageHyperaemia, congestion and haemorrhage
Hyperaemia, congestion and haemorrhage
 
examination of the eye
 examination of the eye examination of the eye
examination of the eye
 
EMBRYOLOGY
EMBRYOLOGYEMBRYOLOGY
EMBRYOLOGY
 
NEURON SUPPORTIVE CELLS OR ANS
NEURON SUPPORTIVE CELLS OR ANSNEURON SUPPORTIVE CELLS OR ANS
NEURON SUPPORTIVE CELLS OR ANS
 
Fertilization early embryo dev't
Fertilization early embryo dev'tFertilization early embryo dev't
Fertilization early embryo dev't
 
General anatomy 18
General anatomy 18General anatomy 18
General anatomy 18
 
General anatomy 19 (b)
General anatomy 19 (b)General anatomy 19 (b)
General anatomy 19 (b)
 
Lecture 19 central nervous system (a)
Lecture 19   central nervous system (a)Lecture 19   central nervous system (a)
Lecture 19 central nervous system (a)
 
Genetic code & transcription
Genetic code & transcriptionGenetic code & transcription
Genetic code & transcription
 
Epidemiology trends and healthcare implication
Epidemiology trends and healthcare implicationEpidemiology trends and healthcare implication
Epidemiology trends and healthcare implication
 
Primary eye care examination
Primary eye care examinationPrimary eye care examination
Primary eye care examination
 
Microeconomics and other social parameters.
Microeconomics and other social parameters.Microeconomics and other social parameters.
Microeconomics and other social parameters.
 
Epidemiology trends and healthcare implication
Epidemiology trends and healthcare implicationEpidemiology trends and healthcare implication
Epidemiology trends and healthcare implication
 
Caring for the blind
Caring for the blindCaring for the blind
Caring for the blind
 
Screening
ScreeningScreening
Screening
 

Recently uploaded

Snam 2023-27 Industrial Plan - Financial Presentation
Snam 2023-27 Industrial Plan - Financial PresentationSnam 2023-27 Industrial Plan - Financial Presentation
Snam 2023-27 Industrial Plan - Financial Presentation
Valentina Ottini
 
Corporate Presentation Probe June 2024.pdf
Corporate Presentation Probe June 2024.pdfCorporate Presentation Probe June 2024.pdf
Corporate Presentation Probe June 2024.pdf
Probe Gold
 
Collective Mining | Corporate Presentation - May 2024
Collective Mining | Corporate Presentation - May 2024Collective Mining | Corporate Presentation - May 2024
Collective Mining | Corporate Presentation - May 2024
CollectiveMining1
 
cyberagent_For New Investors_EN_240424.pdf
cyberagent_For New Investors_EN_240424.pdfcyberagent_For New Investors_EN_240424.pdf
cyberagent_For New Investors_EN_240424.pdf
CyberAgent, Inc.
 
Osisko Development - Investor Presentation - June 24
Osisko Development - Investor Presentation - June 24Osisko Development - Investor Presentation - June 24
Osisko Development - Investor Presentation - June 24
Philip Rabenok
 
New Tax Regime User Guide Flexi Plan Revised (1).pptx
New Tax Regime User Guide Flexi Plan Revised (1).pptxNew Tax Regime User Guide Flexi Plan Revised (1).pptx
New Tax Regime User Guide Flexi Plan Revised (1).pptx
RajkumarRajamanikam
 
Collective Mining | Corporate Presentation - May 2024
Collective Mining | Corporate Presentation - May 2024Collective Mining | Corporate Presentation - May 2024
Collective Mining | Corporate Presentation - May 2024
CollectiveMining1
 
Investor Day 2024 Presentation Sysco 2024
Investor Day 2024 Presentation Sysco 2024Investor Day 2024 Presentation Sysco 2024
Investor Day 2024 Presentation Sysco 2024
Sysco_Investors
 

Recently uploaded (8)

Snam 2023-27 Industrial Plan - Financial Presentation
Snam 2023-27 Industrial Plan - Financial PresentationSnam 2023-27 Industrial Plan - Financial Presentation
Snam 2023-27 Industrial Plan - Financial Presentation
 
Corporate Presentation Probe June 2024.pdf
Corporate Presentation Probe June 2024.pdfCorporate Presentation Probe June 2024.pdf
Corporate Presentation Probe June 2024.pdf
 
Collective Mining | Corporate Presentation - May 2024
Collective Mining | Corporate Presentation - May 2024Collective Mining | Corporate Presentation - May 2024
Collective Mining | Corporate Presentation - May 2024
 
cyberagent_For New Investors_EN_240424.pdf
cyberagent_For New Investors_EN_240424.pdfcyberagent_For New Investors_EN_240424.pdf
cyberagent_For New Investors_EN_240424.pdf
 
Osisko Development - Investor Presentation - June 24
Osisko Development - Investor Presentation - June 24Osisko Development - Investor Presentation - June 24
Osisko Development - Investor Presentation - June 24
 
New Tax Regime User Guide Flexi Plan Revised (1).pptx
New Tax Regime User Guide Flexi Plan Revised (1).pptxNew Tax Regime User Guide Flexi Plan Revised (1).pptx
New Tax Regime User Guide Flexi Plan Revised (1).pptx
 
Collective Mining | Corporate Presentation - May 2024
Collective Mining | Corporate Presentation - May 2024Collective Mining | Corporate Presentation - May 2024
Collective Mining | Corporate Presentation - May 2024
 
Investor Day 2024 Presentation Sysco 2024
Investor Day 2024 Presentation Sysco 2024Investor Day 2024 Presentation Sysco 2024
Investor Day 2024 Presentation Sysco 2024
 

Stimulants

  • 1. 1
  • 2.  Defination “Stimulants are a substance which tends to increase behavioral activity when administered”
  • 3. Few clinical uses, Important as drugs of abuse. Factors that limit the therapeutic usefulness include: 1.Dependence: Psychological and physiological. 2.Tolerance to the euphoric and anorectic effects are classified according to their action into: Psychomotor stimulants Hallucinogen (psychotomimetic or psychedelics) drugs 3
  • 4. 1. Psychomotor stimulants cause: Excitement, Euphoria, Decrease feeling of fatigue & Increase motor activity Ex., Methylxanthines (caffeine, theobromine, theophylline), nicotine, cocaine, amphetamine, atomoxetine, modafinil, methylphenidate. 2. Hallucinogens (psychotomimetic): Affect thought, perception, and mood, therefore produce profound changes in thought patterns & mood, little effect on the brain stem & spinal cord Ex., Lysergic acid diethylamide (LSD), Phencyclidine (PCP), Tetrahydrocannabinol (THC), Rimonabant. 4
  • 5. Q. What are Stimulants? Answer. Chemical stracture are similar to monoamine neurotransmitters. All are indirect- acting sympathomimetics: 1. Many CNS stimulants release catecholamines, Therefore, their effects are abolished by prior treatment with reserpine or guanethidine Ex: amphetamine, dextroamphetamine, methamphetamine, methylphenidate (Ritalin), ephedrine, pseudoephedrine (a stereoisomer of ephedrine), tyramine. 2. Other CNS stimulants block the reuptake of catecholamines (NE and DA) and serotonin: EX. Cocaine, sibutramine (reduct)® , modafinil 5
  • 6. Attention Deficit Hyperactivity Disorder (ADHD); lack the ability to be involved in any one activity for longer than a few minutes. Narcolepsy: It is a relatively rare sleep disorder, that is characterized by uncontrollable bouts of sleepiness during the day. It is sometimes accompanied by catalepsy, a loss in muscle control, or even paralysis brought on by strong emotion, such as laughter. Contraindications: patients with anorexia, insomnia, asthenia, psychopathic personality, a history of homicidal or suicidal tendencies. 6
  • 7. I. Cocaine, Crack (free base or hydrochloride). II. Amphetamines: D-Amphetamine, Methamphetamine, methylphenidate (use to treat attention deficit disorders in children), phenmetrazine (Preludin) - used to treat obesity, III. Methylxanthines: caffeine (coffee), theophyline (tea), theobromide (chocolate).
  • 8.  Alkaloid from Erythroxylon coca  Indigenous to western South America  Coca leaves used for religious, mystical, social, stimulant, and medicinal purposes  Main stimulant uses: endurance, feeling of well-being, alleviate hunger  Medical uses: local anesthetic, vasoconstrictor
  • 9.  alertness/vigilance, concentration  mental acuity, sensory awareness  euphoria/elevated mood  brain electrical activity  self-confidence, grandiosity  need for sleep (insomnia)  appetite  brain blood flow, glucose metabolism London et al., 1999
  • 10.  sexual desire, but cocaine can  performance  anxiety, suspiciousness  convulsions, tremor, seizure  psychosis, delirium  locomotion at low/moderate doses  repetitiveness, stereotypy at high doses  reinforcement/addiction  judgement, complex multi-tasking
  • 11.  Blood pressure  Blood sugar  Heart rate Irregular heart beat Vasoconstriction  Body temperature Bronchodialation & Impaired breathing Fight/Flight/Fright Syndrome (sympathetic nervous system arousal)
  • 12.  Routes of administration ◦ Insufflated (snorted) ◦ IV (mainlined) ◦ Inhaled (freebased) ◦ Oral
  • 13.
  • 14.  Cocaine has a local anesthetic action that represents the only current rationale for the therapeutic use of cocaine.  For example, cocaine is applied topically as a local anesthetic during eye, ear, nose, and throat surgery.  Whereas the local anesthetic action of cocaine is due to a block of voltage-activated sodium channels, an interaction with potassium channels may contribute to the ability of cocaine to cause cardiac arrhythmias.
  • 15.  Both cocaine and amphetamines penetrate BBB easily  Half-lives ◦ Cocaine: ~ 50-90 min ◦ Amphetamine: ~ 5-10 hours ◦ Meth: ~ 12 hours  Metabolites include active and inactive compounds  Cocaine is unusual in that it “autometabolizes” in the blood in addition to normal liver metabolism. ◦ Cocaine ----> norcocaine, ecgonine methyl ester, benzoylecgonine
  • 16.  High abuse potential  Physical and psychological dependence  Tolerance to euphoria, appetite suppression; sensitization to psychomotor  Withdrawal ◦ Physically mild to moderate (hunger, fatigue, anxiety, irritability, depression, panic attacks, dysphoric syndrome)  Dysphoric syndrome (1-5 days after the crash): characterized by decreased activity, amotivation, intense boredom and anhedonia, intense “craving” for cocaine. May last 1-10 weeks.  Intense cravings  Route of administration important to addiction risk
  • 17.  Synthetic analog of ephedrine, active ingredient in mahuang  Mahuang used in China for asthma ◦ Chinese (Mandarin) má huáng : má, hemp + huáng, yellow  Methamphetamine and Methylphenidate (Ritalin) are very similar  Medical uses: obesity, ADHD,
  • 18. Amphetamine is a noncatecholaminergic sympathetic amine that shows neurologic and clinical effects quite similar to those of cocaine. Dextroamphetamine is the major member of this class of compounds. Methamphetamine is a derivative of amphetamine that can be smoked, and it is preferred by many abusers.
  • 19.
  • 20.  Adverse effects:  - Cardiovascular: Hypertension (7% to 22%, pediatric )  - Endocrine metabolic: Weight loss (4% to 9%, pediatric; 11%, adults )  - Gastrointestinal: Abdominal pain (11% to 14%, pediatrics ), Loss of appetite (22% to 36%), Xerostomia (35% )  - Neurologic: Headache (26% ), Insomnia ‫ارق‬ )12 % to 17%, pediatric; 27%, adults )  - Psychiatric: Feeling nervous (6% ) 
  • 21.
  • 22.  After injecting,  the mice with amphetamine you well notice:  - Hair erection  - Licking, gnawing.  - Stereotype  - Sniffing 
  • 23. Methylxanthines  The methylxanthines include theophylline which is found in tea; theobromine found in cocoa; and caffeine .  Caffeine, the most widely consumed stimulant in the world, is found in highest concentration in coffee, but it is also present in tea, cola drinks, chocolate candy, and cocoa.
  • 24. Several mechanisms have been proposed for the actions of methylxanthines, including translocation of extracellular calcium, increase in cyclic adenosine monophosphate and cyclic guanosine monophosphate caused by inhibition of phosphodiesterase, and blockade of adenosine receptors. The latter most likely accounts for the actions achieved by the usual consumption of caffeine- containing beverages
  • 25.  CNS: The caffeine contained in one to two cups of coffee causes a decrease in fatigue and increased mental alertness as a result of stimulating the cortex and other areas of the brain.  Consumption of 1.5 g of caffeine (12 to 15 cups of coffee) produces anxiety and tremors.  The spinal cord is stimulated only by very high doses of caffeine.  Tolerance can rapidly develop to the stimulating properties of caffeine; withdrawal consists of feelings of fatigue and sedation.
  • 26.  Cardiovascular system:  A high dose of caffeine has positive inotropic and chronotropic effects on the heart.  Diuretic action:  Caffeine has a mild diuretic action that increases urinary output of sodium, chloride, and potassium.  Gastric mucosa:  Because all methylxanthines stimulate secretion of hydrochloric acid from the gastric mucosa, individuals with peptic ulcers should avoid beverages containing methylxanthines
  • 27.
  • 28. The methylxanthines are well absorbed orally. Caffeine distributes throughout the body, including the brain. The drugs cross the placenta to the fetus and is secreted into the mother's milk. All the methylxanthines are metabolized in the liver, generally by the CYP1A2 pathway, and the metabolites are then excreted in the urine.
  • 29.  Moderate doses of caffeine cause insomnia, anxiety, and agitation.  The lethal dose is about 10 g of caffeine (about 100 cups of coffee), which induces cardiac arrhythmias; death from caffeine is thus highly unlikely.  Lethargy, irritability, and headache occur in users who have routinely consumed more than 600 mg of caffeine per day (roughly six cups of coffee per day) and then suddenly stop.
  • 30. Nicotine is the active ingredient in tobacco. Although this drug is not currently used therapeutically, nicotine remains important, because it is second only to caffeine as the most widely used CNS stimulant and second only to alcohol as the most abused drug.  In combination with the tars and carbon monoxide found in cigarette smoke, nicotine represents a serious risk factor for lung and cardiovascular disease, various cancers, as well as other illnesses. Dependency on the drug is not easily overcome.
  • 31.  In low doses, nicotine causes ganglionic stimulation by depolarization.  At high doses, nicotine causes ganglionic blockade.  Nicotine receptors exist at a number of sites in the CNS, which participate in the stimulant attributes of the drug.
  • 32.  Nicotine is highly lipid soluble and readily crosses the blood-brain barrier.  Cigarette smoking or administration of low doses of nicotine produces some degree of euphoria and arousal as well as relaxation.  It improves attention, learning, problem solving, and reaction time.  High doses of nicotine result in central respiratory paralysis .
  • 33. Because nicotine is highly lipid soluble, absorption readily occurs via the oral mucosa, lungs, mucosa, and skin. Nicotine crosses the placental membrane and is secreted in the milk of lactating women. By inhaling tobacco smoke, the average smoker takes in 1 to 2 mg of nicotine per cigarette (most cigarettes contain 6 to 8 mg of nicotine). The acute lethal dose is 60 mg. More than 90 percent of the nicotine inhaled in smoke is absorbed.
  • 34.  The CNS effects of nicotine include irritability and tremors.  Nicotine may also cause intestinal cramps, diarrhea, and increased heart rate and blood pressure.  In addition, cigarette smoking increases the rate of metabolism of number of drugs.